IGF-1, Training, and Exercise: How Physical Activity Shapes Your Levels

What IGF-1 Actually Measures

IGF-1 (insulin-like growth factor 1) is a 70-amino-acid peptide produced mainly in the liver in response to growth hormone (GH) signaling. Unlike GH itself, which pulses every 2 to 3 hours, IGF-1 circulates at stable concentrations bound to insulin-like growth factor binding protein 3 (IGFBP-3). That stability makes it a far better lab marker than a single GH draw. A 2021 review in the Journal of Clinical Endocrinology and Metabolism confirmed that serum IGF-1 remains the standard surrogate for integrated 24-hour GH secretion in clinical practice.

Why the GH-IGF-1 Axis Matters for Athletes and Aging Adults

GH binds hepatic GH receptors, triggering JAK2-STAT5b phosphorylation and subsequent IGF-1 transcription. IGF-1 then acts on muscle, bone, and adipose tissue to promote protein synthesis, satellite cell activation, and lipolysis. Giustina et al., writing in the Endocrine Society's 2019 consensus statement, described IGF-1 as "the best single serum marker of GH action at the tissue level" because it integrates hepatic responsiveness, nutritional status, and cumulative GH exposure.

IGF-1 Normal Range by Age

IGF-1 declines roughly 14% per decade after age 30. The Endocrine Society's clinical practice guideline on adult GH deficiency recommends interpreting all IGF-1 values against age- and sex-matched normative data rather than a single universal cutoff. Approximate adult reference ranges from standard laboratory assays (Immulite 2000, Quest Diagnostics):

| Age range | Male IGF-1 (ng/mL) | Female IGF-1 (ng/mL) | |---|---|---| | 18 to 29 | 152 to 364 | 140 to 328 | | 30 to 39 | 116 to 290 | 112 to 268 | | 40 to 49 | 101 to 267 | 98 to 252 | | 50 to 59 | 88 to 246 | 85 to 236 | | 60 to 69 | 75 to 212 | 72 to 205 | | 70+ | 62 to 190 | 60 to 185 |

These ranges are assay-specific. If your lab uses a different platform, request the platform-specific reference interval.

How Resistance Training Raises IGF-1

Resistance exercise produces the most pronounced acute IGF-1 response of any exercise modality. The magnitude depends on load, volume, rest interval length, and muscle mass recruited.

Acute Post-Exercise Spike

A controlled trial by Kraemer and Ratamess published in Endocrine Reviews (2005) documented a 20 to 35% increase in serum IGF-1 within 15 to 30 minutes of completing a high-volume resistance session (10 sets, 10 reps at 70% 1-RM, 90-second rest intervals) in trained men aged 20 to 35. The spike is driven partly by hepatic release and partly by local muscle IGF-1 (mechano-growth factor, MGF), which is an alternatively spliced isoform that acts in a paracrine fashion.

Short rest intervals (60 to 90 seconds) between sets produce higher GH and IGF-1 responses than long rest intervals (3 minutes or more) at equivalent total volume. A study of 12 trained men in the Journal of Strength and Conditioning Research (Goto et al., 2005) confirmed that short-rest protocols elevated serum GH to 3.7-fold above baseline versus 1.4-fold in the long-rest condition, and IGF-1 tracked proportionally.

Chronic Adaptations from Consistent Resistance Training

A 12-week progressive resistance program (3 sessions per week, compound movements, progressive overload) raises resting IGF-1 by approximately 10 to 25% in previously sedentary adults. A meta-analysis by Nindl et al. (Eur J Appl Physiol, 2010) pooling data from 21 intervention studies found that training-induced IGF-1 increases were greatest in participants who began with the lowest baseline values, suggesting a ceiling effect in already-trained individuals.

The type of movement matters. Multi-joint compound lifts (squat, deadlift, bench press, overhead press) recruit more total muscle mass and drive larger GH pulses than isolation exercises. Programming that pairs compound movements with 3 to 5 sets of 6 to 12 repetitions at 70 to 85% 1-RM appears to be the strongest stimulus for sustained IGF-1 elevation.

Overtraining Suppresses the Axis

Paradoxically, excessive volume without adequate recovery can suppress IGF-1. Hartman et al. (2006) in the Journal of Applied Physiology showed that 8 weeks of twice-daily resistance training in male athletes reduced resting IGF-1 by 12% compared to once-daily training, accompanied by elevated cortisol-to-testosterone ratios. Recovery, including sleep quality and caloric sufficiency, is as important as training stimulus.

Aerobic Exercise and IGF-1: A More Modest Relationship

Endurance training affects IGF-1 through different mechanisms than resistance work. The acute GH spike during steady-state aerobic exercise is blunted compared to resistance training, but chronic adaptations are meaningful.

Acute Aerobic Response

Moderate-intensity continuous training (MICT) at 60 to 70% VO2max for 45 to 60 minutes produces a modest GH pulse, typically 1.5 to 2-fold above resting baseline, with a correspondingly smaller IGF-1 rise. High-intensity interval training (HIIT) produces a larger acute GH response. A crossover study by Godfrey et al. (2003) in the European Journal of Applied Physiology compared sprint intervals (6 x 10-second maximal sprints) to 30 minutes of continuous cycling at 65% VO2max and found the sprint protocol elevated serum GH to 6-fold above baseline versus 2.5-fold for continuous work.

Chronic Aerobic Training Effects

Long-term aerobic conditioning, defined as 5 or more hours per week for at least 12 weeks, raises resting IGF-1 by approximately 10 to 20% in sedentary adults. Eliakim et al. (1996) demonstrated that a 5-week endurance training program in adolescent females increased IGF-1 by 22%, with changes correlating to increases in VO2max. The mechanism involves improved hepatic GH receptor sensitivity rather than increased GH pulse frequency.

Elite endurance athletes often display IGF-1 values near the high end of the normal reference range for their age group, a pattern consistent with decades of chronic stimulus. Very high training volumes without adequate energy availability (as seen in Relative Energy Deficiency in Sport, RED-S) can suppress IGF-1 by restricting the caloric substrate needed for hepatic IGF-1 synthesis.

Nutrition, Sleep, and Other Lifestyle Factors That Confound IGF-1

Exercise does not operate in isolation. Several non-training variables shift IGF-1 substantially and must be accounted for when interpreting a single lab draw.

Protein and Total Caloric Intake

IGF-1 synthesis is directly tied to amino acid availability. A controlled feeding study by Clemmons et al. (2001) in the Journal of Clinical Endocrinology and Metabolism showed that dietary protein below 0.8 g/kg/day reduced serum IGF-1 by up to 30% even when total calories were sufficient. Conversely, increasing protein to 1.6 to 2.2 g/kg/day in resistance-trained individuals raised IGF-1 toward the upper third of the age-adjusted reference range. Short-term fasting of 5 days or more reliably drops IGF-1 by 50 to 70% through GH resistance at the hepatic receptor, as confirmed in Thissen et al. (1994) in Endocrine Reviews.

Sleep Architecture

GH secretion is tightly coupled to slow-wave sleep (SWS), specifically stages N3 and N4. Poor sleep quality, defined operationally as less than 90 minutes of SWS per night, substantially reduces overnight GH pulsatility and therefore suppresses IGF-1. Van Cauter et al. (2000) in JAMA showed that age-related declines in SWS explained a significant fraction of the age-related drop in GH secretion, independent of body composition.

Alcohol

Alcohol acutely blunts GH secretion. Even moderate intake (two standard drinks consumed in the evening) can suppress the overnight GH pulse by 70 to 75%, as shown in Prinz et al. (1980) in the Journal of Studies on Alcohol. Chronic heavy drinking lowers mean 24-hour IGF-1 by 30 to 40%, partly through direct hepatotoxicity.

Body Composition

Visceral adiposity independently suppresses IGF-1. Higher circulating free fatty acids and elevated insulin in the insulin-resistant state reduce hepatic GH receptor expression. Veldhuis et al. (2005) in the Journal of Clinical Endocrinology and Metabolism found that waist circumference was the single strongest negative predictor of IGF-1 in a cohort of 200 middle-aged adults, accounting for 38% of the variance in serum levels.

What Is the Optimal IGF-1 Level?

"Optimal" is context-dependent and contested. Reference range and optimal range are not the same thing.

Longevity-Focused Targets

Longevity medicine practitioners often cite a target band of 120 to 200 ng/mL for adults aged 40 to 70, based on epidemiological data showing that both very low and very high IGF-1 associate with adverse outcomes. Renehan et al. (2004) in The Lancet published a landmark meta-analysis of 4,000 subjects across multiple studies showing that higher IGF-1 within the normal range correlated with increased risk for colorectal, prostate, and breast cancers. The absolute risk increase was small, but it underscores that pushing IGF-1 to the top of the reference range via pharmacological means carries tradeoffs.

At the other extreme, a prospective cohort study of 633 adults followed for 20 years (Juul et al., 2002, Eur J Endocrinol) found that IGF-1 in the lowest quartile associated with a 2.1-fold higher all-cause mortality risk compared to the highest quartile, with cardiovascular disease being the dominant driver.

Athletic Performance Targets

For athletes prioritizing muscle hypertrophy and recovery, values in the upper half of the age-adjusted reference range, roughly the 50th to 75th percentile, appear consistent with optimal anabolic signaling without pharmacological support. There is no published trial demonstrating that pushing IGF-1 above the reference range through GH or peptide therapy improves athletic performance in healthy adults, and the FDA has not approved GH for athletic performance enhancement.

A Practical Three-Zone IGF-1 Interpretation Framework

Clinicians at HealthRX use a three-zone model when reviewing IGF-1 results alongside training history:

Zone 1 (Deficiency zone): IGF-1 below the age-adjusted 10th percentile. Warrants formal GH stimulation testing and endocrinology referral. Common causes include pituitary pathology, severe malnutrition, hypothyroidism, or chronic systemic illness.

Zone 2 (Optimization zone): IGF-1 between the 25th and 75th percentile for age and sex. Most lifestyle and training interventions aim to place patients here. Peptide therapies such as sermorelin, CJC-1295, or ipamorelin are sometimes used to push values from the lower portion of Zone 2 toward the midpoint.

Zone 3 (Excess zone): IGF-1 above the age-adjusted 90th percentile, or any value above 300 ng/mL in adults over 40. Requires ruling out acromegaly, active GH-secreting adenoma, or exogenous GH misuse before attributing the elevation to training alone.

IGF-1 and GH Peptide Therapy: The Lab Connection

GH secretagogues such as sermorelin (GHRH analog) and ipamorelin/CJC-1295 work by stimulating endogenous GH pulsatility rather than replacing GH directly. The Endocrine Society's 2019 guidelines on adult GH deficiency specify that a confirmed low IGF-1 plus a failed GH stimulation test are both required before initiating replacement GH therapy. Peptide secretagogues occupy a different regulatory category, but responsible prescribing still relies on baseline and follow-up IGF-1 measurements to titrate dosing.

Monitoring IGF-1 During Peptide Protocols

A standard monitoring schedule during sermorelin or ipamorelin/CJC-1295 therapy includes:

• Baseline IGF-1 draw (fasted morning specimen, no training 24 hours prior)
• Recheck at 6 to 8 weeks post-initiation
• Quarterly draws thereafter for the first year
• Dose adjustment targeting the 50th, 75th percentile of the age-adjusted range

Target titration avoids pushing IGF-1 into Zone 3. Most patients on 100 to 200 mcg nightly ipamorelin see IGF-1 increases of 30 to 70 ng/mL over 12 weeks, depending on baseline value, protein intake, and sleep quality.

Pre-Draw Standardization for Accurate Testing

IGF-1 is more stable than GH, but acute exercise still produces a measurable transient elevation that can inflate a result by 15 to 25%. To get a true resting baseline:

1. Draw blood in the fasted state (8 to 12 hours, water only).
2. Avoid resistance training for 24 hours before the draw.
3. Aim for a morning draw between 07:00 and 09:00 to minimize diurnal variation.
4. Report any recent illness, caloric restriction, or alcohol use to the ordering provider, as each can suppress values and mask true deficiency.

A 2009 review in Growth Hormone and IGF Research confirmed that pre-analytical standardization reduces within-individual CV from approximately 18% to under 8%, making serial monitoring far more clinically reliable.

Special Populations: Sex Differences and Aging

Women typically have IGF-1 values 10 to 15% lower than age-matched men throughout adult life, partly because estrogen reduces hepatic GH receptor sensitivity. Ho et al. (1987) in the Journal of Clinical Endocrinology and Metabolism characterized this sex difference in 24-hour GH secretion profiles, noting that women have higher GH pulse frequency but lower hepatic IGF-1 output per pulse. Oral estrogens (as opposed to transdermal) suppress IGF-1 further, an effect not seen with transdermal estradiol, because oral delivery creates a supraphysiological first-pass hepatic exposure.

After menopause, IGF-1 drops an additional 15 to 20% as estrogen-mediated GH secretion declines. Training adaptations in this group tend to be smaller in absolute IGF-1 terms but proportionally similar to younger women. Protein intake at or above 1.6 g/kg/day remains a modifiable variable that can partially compensate.

In men, testosterone positively regulates GH pulsatility and hepatic IGF-1 production. Men with low testosterone (total T below 300 ng/dL) often display IGF-1 values in the lower third of the reference range, even with consistent training. Correcting testosterone deficiency commonly raises IGF-1 by 20 to 40 ng/mL independently of changes in training volume.

Practical Training Recommendations to Optimize IGF-1

Based on the evidence above, these programming principles are most likely to raise IGF-1 into the 50th, 75th percentile for age and sex in a healthy adult:

Resistance Training Protocol

• Frequency: 3 to 4 sessions per week
• Exercise selection: prioritize multi-joint compound movements (squat, hip hinge, horizontal and vertical push/pull)
• Load: 70 to 85% of estimated 1-RM
• Volume: 3 to 5 sets of 6 to 12 repetitions per movement
• Rest intervals: 60 to 90 seconds between sets to maximize GH response
• Progressive overload: increase load or volume by 3 to 5% every 1 to 2 weeks

Aerobic Conditioning Protocol

• Include 1 to 2 HIIT sessions per week (e.g., 6 to 8 x 30-second all-out intervals with 90-second recovery)
• Maintain 2 to 3 moderate-intensity aerobic sessions at 65 to 75% max heart rate for cardiovascular and metabolic health
• Avoid exceeding 10 to 12 hours per week of total aerobic volume without proportional caloric increase

Recovery and Nutrition Targets

• Sleep: 7 to 9 hours per night with attention to SWS quality (cool room, no screens 60 minutes before bed, alcohol avoided after 18:00)
• Protein: 1.6 to 2.2 g/kg/day distributed across 3 to 4 meals
• Total calories: no sustained deficit exceeding 500 kcal/day if IGF-1 optimization is the goal
• Zinc and magnesium adequacy: both micronutrients support GH axis function; serum zinc below 70 mcg/dL independently associates with reduced IGF-1 in a cross-sectional study of 395 adults (Nishi, 1996, Journal of the American College of Nutrition)